Pragmatic clinical trials for treating relapsing multiple sclerosis

被引：4

作者：

Mowry, Ellen M. ^{[1
]}

Ontaneda, Daniel ^{[2
]}

Evangelou, Nikos ^{[3
]}

Newsome, Scott D. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21287 USA

[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis, Cleveland, OH 44106 USA

[3] Univ Nottingham, Div Clin Neurosci, Clin Neurol, Nottingham, England

来源：

LANCET NEUROLOGY | 2019年 / 18卷 / 12期

关键词：

DISEASE-MODIFYING THERAPY;

D O I：

10.1016/S1474-4422(19)30386-2

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1075 / 1075

页数：1

共 6 条

[1] Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis [J].

Brown, J. William L. ;

Coles, Alasdair ;

Horakova, Dana ;

Havrdova, Eva ;

Izquierdo, Guillermo ;

Prat, Alexandre ;

Girard, Marc ;

Duquette, Pierre ;

Trojano, Maria ;

Lugaresi, Alessandra ;

Bergamaschi, Roberto ;

Grammond, Pierre ;

Alroughani, Raed ;

Hupperts, Raymond ;

McCombe, Pamela ;

Van Pesch, Vincent ;

Sola, Patrizia ;

Ferraro, Diana ;

Grand'Maison, Francois ;

Terzi, Murat ;

Lechner-Scott, Jeannette ;

Flechter, Schlomo ;

Slee, Mark ;

Shaygannejad, Vahid ;

Pucci, Eugenio ;

Granella, Franco ;

Jokubaitis, Vilija ;

Willis, Mark ;

Rice, Claire ;

Scolding, Neil ;

Wilkins, Alastair ;

Pearson, Owen R. ;

Ziemssen, Tjalf ;

Hutchinson, Michael ;

Harding, Katharine ;

Jones, Joanne ;

McGuigan, Christopher ;

Butzkueven, Helmut ;

Kalincik, Tomas ;

Robertson, Neil ;

Onofrj, Marco ;

De Luca, Giovanna ;

Di Tommaso, Valeria ;

Travaglini, Daniela ;

Pietrolongo, Erika ;

di Ioia, Maria ;

Farina, Deborah ;

Mancinelli, Luca ;

Hodgkinson, Suzanne ;

Oreja-Guevara, Celia .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (02) :175-187

[2] Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial [J].

Coles, Alasdair J. ;

Twyman, Cary L. ;

Arnold, Douglas L. ;

Cohen, Jeffrey A. ;

Confavreux, Christian ;

Fox, Edward J. ;

Hartung, Hans-Peter ;

Havrdova, Eva ;

Selmaj, Krzysztof W. ;

Weiner, Howard L. ;

Miller, Tamara ;

Fisher, Elizabeth ;

Sandbrink, Rupert ;

Lake, Stephen L. ;

Margolin, David H. ;

Oyuela, Pedro ;

Panzara, Michael A. ;

Compston, D. Alastair S. .

LANCET, 2012, 380 (9856) :1829-1839

[3] Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research [J].

Freemantle, Nick ;

Marston, Louise ;

Walters, Kate ;

Wood, John ;

Reynolds, Matthew R. ;

Petersen, Irene .

BMJ-BRITISH MEDICAL JOURNAL, 2013, 347

[4] Do we have equipoise when it comes to how we treat active multiple sclerosis? [J].

Giovannoni, Gavin .

LANCET NEUROLOGY, 2019, 18 (10) :909-911

[5] Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis [J].

Kappos, L. ;

Wiendl, H. ;

Selmaj, K. ;

Arnold, D. L. ;

Havrdova, E. ;

Boyko, A. ;

Kaufman, M. ;

Rose, J. ;

Greenberg, S. ;

Sweetser, M. ;

Riester, K. ;

O'Neill, G. ;

Elkins, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (15) :1418-1428

[6] Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis [J].

Ontaneda, Daniel ;

Tallantyre, Emma ;

Kalincik, Tomas ;

Planchon, Sarah M. ;

Evangelou, Nikos .

LANCET NEUROLOGY, 2019, 18 (10) :973-980

← 1 →